Clioquinol

Generic name
Clioquinol
Brand name
ATC Code
P01AA02
Compare …

Clioquinol

Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Pharmacokinetics in children

No information.

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

Dientamoebiasis (if other drugs have not had sufficient effect), amoebiasis
  • Oral
    • 1 month up to 18 years
      • 15 mg/kg/day in 3 doses. Max: 750 mg/day.
      • Duration of treatment:

        The maximum cumulative duration of treatment is 10 days.

        • Amoebiasis: prior to treatment with metronidazole
        • Treatment after consultation with a paediatrician-infectiologist

Renal impaiment in children > 3 months

No information available on dose adjustment in renal impairment.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions in children

Due to the neurotoxicity that can occur with a cumulative dose of 10 grams, a check should be made of whether clioquinol has been used before.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES

This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.

Nitroimidazole derivatives
P01AB01
Other agents against amoebiasis and other protozoal diseases
P01AX06

References

  1. Hartwig, N.C. et al, Vademecum Pediatrische antimicrobiele therapie, 2005
  2. Furth van AM et al, Werkboek Infectieziekten bij Kinderen, VU Uitgeverij, 1999

Changes

Therapeutic Drug Monitoring


Overdose